Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Psychoses, Substance-Induced »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Psychophysiology < Psychoses, Substance-Induced < Psychosurgery  Facettes :

List of bibliographic references indexed by Psychoses, Substance-Induced

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000C50 (2013) James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. BrotchieThe effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001986 (2010) Susan H. Fox [Canada] ; Jonathan M. BrotchieThe MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
002B55 (2004) Harold D. Foster [Canada] ; Abram HofferThe two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
002F82 (2002) Philip Seeman [Canada]Atypical antipsychotics: mechanism of action.
003561 (2000) Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
003E88 (1996) P. Sandor [Canada] ; A. E. Lang [Canada] ; S. Singal [Canada] ; C. Augus [Canada]Remoxipride in the treatment of levodopa-induced psychosis
004208 (1994) Brigitte Mendis [Canada] ; Erich Mohr [Canada] ; Amanda George [Canada] ; Ilene N. Rusk [Canada] ; Peggy Gray [Canada] ; J. David Grimes [Canada]Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride
004429 (1993) A. H. Rajput [Canada] ; B. Rozdilsky [Canada] ; Alex Rajput [Canada]Alzheimer's Disease and Idiopathic Parkinson's Disease Coexistence
004A04 (1990) E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. CalneClozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis
004B38 (1989) E. C. Wolters ; T. A. Hurwitz ; R. F. Peppard ; D. B. CalneClozapine: an antipsychotic agent in Parkinson's disease?
005664 (????) D S Sa [Canada] ; S. Kapur ; A E LangAmoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Psychoses, Substance-Induced" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Psychoses, Substance-Induced" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Psychoses, Substance-Induced
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022